Sleep Number Under Investigation Amid Poor Earnings Report
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Source: Globenewswire
- Earnings Miss: Sleep Number reported a GAAP EPS of -$2.19 for Q1 2026, missing consensus estimates by $1.72, with revenue of $318.99 million falling short by $1.73 million and reflecting an 18.9% year-over-year decline, indicating severe financial distress for the company.
- Guidance Suspension: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests it is actively seeking solutions to address its current challenges, potentially impacting investor confidence.
- Stock Price Plunge: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting strong market concerns over the company's financial health and possibly prompting investor sell-offs.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, and if confirmed, this could lead to class action lawsuits, further exacerbating the company's legal and financial risks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SNBR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SNBR
Wall Street analysts forecast SNBR stock price to rise
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 0.585
Low
5.00
Averages
5.50
High
6.00
Current: 0.585
Low
5.00
Averages
5.50
High
6.00
About SNBR
Sleep Number Corporation is a wellness technology company. The Company is engaged in designing, manufacturing, marketing, and distribution of sleep solutions. Its wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through its Climate360 smart bed or applying its 24 billion hours of longitudinal sleep data and expertise to research with global institutions. The Company’s smart beds provide unmatched features, benefits and comfort that can lead to improved sleep health and wellness for both sleepers. Its active temperature balancing technology supports the ideal climate for both sleepers and solves a prevalent sleep challenge. The Company’s smart bed ecosystem includes a full line of FlexFit smart adjustable bases that seamlessly integrate with Sleep Number smart beds for an individualized sleep experience that is proven to deliver more restful sleep per night.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sleep Number Under Investigation Amid Poor Earnings Report
- Earnings Miss: Sleep Number reported a GAAP EPS of -$2.19 for Q1 2026, missing consensus estimates by $1.72, with revenue of $318.99 million falling short by $1.73 million and reflecting an 18.9% year-over-year decline, indicating severe financial distress for the company.
- Guidance Suspension: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests it is actively seeking solutions to address its current challenges, potentially impacting investor confidence.
- Stock Price Plunge: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting strong market concerns over the company's financial health and possibly prompting investor sell-offs.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, and if confirmed, this could lead to class action lawsuits, further exacerbating the company's legal and financial risks.
See More
Sleep Number Under Investigation for Securities Fraud Claims
- Securities Fraud Investigation: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud claims against Sleep Number Corporation, focusing on whether the company and its executives engaged in unlawful business practices that could harm shareholders.
- Poor Financial Performance: In its Q1 2026 report, Sleep Number reported a GAAP loss of $2.19 per share, missing consensus estimates by $1.72, with revenue of $318.99 million falling short by $1.73 million, indicating a severe deterioration in the company's financial health.
- Stock Price Plummet: Following the earnings report, Sleep Number's stock fell by $0.55, or 22.45%, closing at $1.90, and on June 4, the stock dropped an additional 70%, now trading at $0.35, reflecting extreme market pessimism about the company's future.
- Increased Bankruptcy Risk: The company has suspended its financial guidance and is working with Guggenheim Securities to evaluate strategic and financing options, suggesting a potential bankruptcy filing, which heightens investor concerns significantly.
See More
Investigation into Potential Securities Fraud at Sleep Number Corporation
- Financial Performance Decline: Sleep Number reported a GAAP loss of $2.19 per share for Q1 2026, missing consensus estimates by $1.72, while revenue of $318.99 million also fell short, indicating severe financial distress that could undermine investor confidence.
- Stock Price Plunge: Following the earnings report on May 12, Sleep Number's stock dropped $0.55, or 22.45%, and further plummeted 70% on June 4, now trading at $0.35, reflecting extreme market pessimism regarding its future prospects.
- Increased Bankruptcy Risk: The company is laying the groundwork for a potential bankruptcy filing and has suspended its financial guidance, highlighting escalating financial pressures and uncertainties that may lead to further investor withdrawals and exacerbate stock declines.
- Legal Investigation Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud involving Sleep Number and its executives, which, if substantiated, could result in significant legal liabilities and damages, further impacting the company's market reputation and shareholder interests.
See More
Sleep Number Under Investigation for Potential Securities Fraud
- Securities Fraud Investigation: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud and other unlawful business practices concerning Sleep Number Corporation, which may significantly impact shareholder interests and highlight governance risks within the company.
- Poor Financial Performance: In its Q1 2026 report, Sleep Number reported a GAAP loss of $2.19 per share, missing consensus estimates by $1.72, with revenue of $318.99 million falling short by $1.73 million, indicating severe financial challenges facing the company.
- Stock Price Plummet: Following the earnings report, Sleep Number's stock price fell by 22.45% to $1.90 on May 12, 2026, and has since dropped an additional 70% to $0.35 today, reflecting extreme market pessimism regarding the company's future.
- Increased Bankruptcy Risk: The company is laying the groundwork for a potential bankruptcy filing and has suspended its financial guidance, indicating a pressing liquidity crisis and urgent strategic decisions that could lead to significant shareholder losses.
See More
Sleep Number Under Investigation for Potential Securities Fraud
- Financial Performance Decline: Sleep Number reported a GAAP earnings loss of $2.19 per share for Q1 2026, missing consensus estimates by $1.72, with revenue of $318.99 million also falling short, indicating severe financial distress for the company.
- Stock Price Plummet: Following the earnings release, Sleep Number's stock fell by $0.55, or 22.45%, closing at $1.90 on May 12, reflecting strong market concerns regarding its financial health.
- Potential Bankruptcy Risk: Today, Sleep Number's stock dropped an additional 70%, now trading at $0.35, suggesting the company is laying the groundwork for a potential bankruptcy filing, further exacerbating investor anxiety.
- Legal Investigation Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud involving Sleep Number and its executives, indicating serious governance and compliance issues that could lead to legal claims from affected investors.
See More
Sleep Number Under Investigation Amid Poor Financial Results
- Declining Financial Performance: Sleep Number reported a GAAP earnings per share of -$2.19 for Q1 2026, missing consensus estimates by $1.72, while revenue of $318.99 million fell short by $1.73 million and represented an 18.9% year-over-year decline, indicating severe financial distress for the company.
- Suspension of Financial Guidance: The company announced the suspension of its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, suggesting a potential restructuring or financing effort to address its current challenges.
- Significant Stock Price Drop: Following the earnings report, Sleep Number's stock price fell by $0.55, a decline of 22.45%, closing at $1.90 per share, reflecting investor concerns regarding the company's future outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, which could further damage the company's reputation and shareholder confidence.
See More
Sleep Number Under Investigation Amid Poor Earnings Report
- Earnings Miss: Sleep Number reported a GAAP EPS of -$2.19 for Q1 2026, missing consensus estimates by $1.72, with revenue of $318.99 million falling short by $1.73 million and reflecting an 18.9% year-over-year decline, indicating severe financial distress for the company.
- Guidance Suspension: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests it is actively seeking solutions to address its current challenges, potentially impacting investor confidence.
- Stock Price Plunge: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting strong market concerns over the company's financial health and possibly prompting investor sell-offs.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, and if confirmed, this could lead to class action lawsuits, further exacerbating the company's legal and financial risks.
See More
Sleep Number Under Investigation for Securities Fraud Claims
- Securities Fraud Investigation: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud claims against Sleep Number Corporation, focusing on whether the company and its executives engaged in unlawful business practices that could harm shareholders.
- Poor Financial Performance: In its Q1 2026 report, Sleep Number reported a GAAP loss of $2.19 per share, missing consensus estimates by $1.72, with revenue of $318.99 million falling short by $1.73 million, indicating a severe deterioration in the company's financial health.
- Stock Price Plummet: Following the earnings report, Sleep Number's stock fell by $0.55, or 22.45%, closing at $1.90, and on June 4, the stock dropped an additional 70%, now trading at $0.35, reflecting extreme market pessimism about the company's future.
- Increased Bankruptcy Risk: The company has suspended its financial guidance and is working with Guggenheim Securities to evaluate strategic and financing options, suggesting a potential bankruptcy filing, which heightens investor concerns significantly.
See More
Investigation into Potential Securities Fraud at Sleep Number Corporation
- Financial Performance Decline: Sleep Number reported a GAAP loss of $2.19 per share for Q1 2026, missing consensus estimates by $1.72, while revenue of $318.99 million also fell short, indicating severe financial distress that could undermine investor confidence.
- Stock Price Plunge: Following the earnings report on May 12, Sleep Number's stock dropped $0.55, or 22.45%, and further plummeted 70% on June 4, now trading at $0.35, reflecting extreme market pessimism regarding its future prospects.
- Increased Bankruptcy Risk: The company is laying the groundwork for a potential bankruptcy filing and has suspended its financial guidance, highlighting escalating financial pressures and uncertainties that may lead to further investor withdrawals and exacerbate stock declines.
- Legal Investigation Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud involving Sleep Number and its executives, which, if substantiated, could result in significant legal liabilities and damages, further impacting the company's market reputation and shareholder interests.
See More
Sleep Number Under Investigation for Potential Securities Fraud
- Securities Fraud Investigation: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud and other unlawful business practices concerning Sleep Number Corporation, which may significantly impact shareholder interests and highlight governance risks within the company.
- Poor Financial Performance: In its Q1 2026 report, Sleep Number reported a GAAP loss of $2.19 per share, missing consensus estimates by $1.72, with revenue of $318.99 million falling short by $1.73 million, indicating severe financial challenges facing the company.
- Stock Price Plummet: Following the earnings report, Sleep Number's stock price fell by 22.45% to $1.90 on May 12, 2026, and has since dropped an additional 70% to $0.35 today, reflecting extreme market pessimism regarding the company's future.
- Increased Bankruptcy Risk: The company is laying the groundwork for a potential bankruptcy filing and has suspended its financial guidance, indicating a pressing liquidity crisis and urgent strategic decisions that could lead to significant shareholder losses.
See More
Sleep Number Under Investigation for Potential Securities Fraud
- Financial Performance Decline: Sleep Number reported a GAAP earnings loss of $2.19 per share for Q1 2026, missing consensus estimates by $1.72, with revenue of $318.99 million also falling short, indicating severe financial distress for the company.
- Stock Price Plummet: Following the earnings release, Sleep Number's stock fell by $0.55, or 22.45%, closing at $1.90 on May 12, reflecting strong market concerns regarding its financial health.
- Potential Bankruptcy Risk: Today, Sleep Number's stock dropped an additional 70%, now trading at $0.35, suggesting the company is laying the groundwork for a potential bankruptcy filing, further exacerbating investor anxiety.
- Legal Investigation Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced an investigation into potential securities fraud involving Sleep Number and its executives, indicating serious governance and compliance issues that could lead to legal claims from affected investors.
See More
Sleep Number Under Investigation Amid Poor Financial Results
- Declining Financial Performance: Sleep Number reported a GAAP earnings per share of -$2.19 for Q1 2026, missing consensus estimates by $1.72, while revenue of $318.99 million fell short by $1.73 million and represented an 18.9% year-over-year decline, indicating severe financial distress for the company.
- Suspension of Financial Guidance: The company announced the suspension of its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, suggesting a potential restructuring or financing effort to address its current challenges.
- Significant Stock Price Drop: Following the earnings report, Sleep Number's stock price fell by $0.55, a decline of 22.45%, closing at $1.90 per share, reflecting investor concerns regarding the company's future outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, which could further damage the company's reputation and shareholder confidence.
See More
